Dataset Information
Brivaracetam add-on therapy for drug-resistant epilepsy.
Ontology highlight
ABSTRACT:
SUBMITTER: Bresnahan R
PROVIDER: S-EPMC6437881 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
Publications
Brivaracetam add-on therapy for drug-resistant epilepsy.
The Cochrane database of systematic reviews 20190328
<h4>Background</h4>Epilepsy is one of the most common neurological disorders. It is estimated that up to 30% of patients with epilepsy continue to have epileptic seizures despite treatment with an antiepileptic drug. These patients are classified as drug-resistant and require treatment with a combination of multiple antiepileptic drugs. Brivaracetam is a third-generation antiepileptic drug that is a high-affinity ligand for synaptic vesicle protein 2A. This review investigates the use of brivara ...[more]